These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21283728)

  • 41. Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain).
    Budoff MJ; Mayrhofer T; Ferencik M; Bittner D; Lee KL; Lu MT; Coles A; Jang J; Krishnam M; Douglas PS; Hoffmann U;
    Circulation; 2017 Nov; 136(21):1993-2005. PubMed ID: 28847895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism.
    Ruchat SM; Vohl MC; Weisnagel SJ; Rankinen T; Bouchard C; Pérusse L
    Ann Med; 2010 Apr; 42(3):196-206. PubMed ID: 20384434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease.
    Ikeda N; Hara H; Hiroi Y; Nakamura M
    Atherosclerosis; 2016 Oct; 253():1-6. PubMed ID: 27569457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of metabolic genetic variants on long-term disease comorbidity in patients with type 2 diabetes.
    Abedian S; Abbasi A; de Boer A; Stricker BH; Bakker SJL; van der Harst P; Sedaghat S; Darvishian M; Ikram MA; Navis G; Dehghan A; Pen I; Stolk RP; Snieder H; Klungel OH; Souverein P; Alizadeh BZ
    Sci Rep; 2021 Feb; 11(1):2794. PubMed ID: 33531528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes.
    Al-Daghri NM; Al-Attas OS; Alokail MS; Alkharfy KM; Hussain T
    Mol Biol Rep; 2011 Aug; 38(6):3703-8. PubMed ID: 21400095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin converting enzyme insertion/deletion (I/D) (rs4646994) and Vegf polymorphism (+405G/C; rs2010963) in type II diabetic patients: Association with the risk of coronary artery disease.
    Moradzadegan A; Vaisi-Raygani A; Nikzamir A; Rahimi Z
    J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):672-80. PubMed ID: 24505095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Individual and cumulative effect of type 2 diabetes genetic susceptibility variants on risk of coronary heart disease.
    Pfister R; Barnes D; Luben RN; Khaw KT; Wareham NJ; Langenberg C
    Diabetologia; 2011 Sep; 54(9):2283-7. PubMed ID: 21638130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic variation at the coronary artery disease risk locus GUCY1A3 modifies cardiovascular disease prevention effects of aspirin.
    Hall KT; Kessler T; Buring JE; Passow D; Sesso HD; Zee RYL; Ridker PM; Chasman DI; Schunkert H
    Eur Heart J; 2019 Nov; 40(41):3385-3392. PubMed ID: 31228190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of ALOX12 gene polymorphism with all-cause and cardiovascular mortality in diabetic nephropathy.
    Roumeliotis AK; Roumeliotis SK; Panagoutsos SA; Tsetsos F; Georgitsi M; Manolopoulos V; Paschou P; Passadakis PS
    Int Urol Nephrol; 2018 Feb; 50(2):321-329. PubMed ID: 29196930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Tavilani H; Pourmotabbed T
    Mol Biol Rep; 2010 Apr; 37(4):2083-91. PubMed ID: 19685167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical risk factors, DNA variants, and the development of type 2 diabetes.
    Lyssenko V; Jonsson A; Almgren P; Pulizzi N; Isomaa B; Tuomi T; Berglund G; Altshuler D; Nilsson P; Groop L
    N Engl J Med; 2008 Nov; 359(21):2220-32. PubMed ID: 19020324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GNB3 gene 825 TT variant predicts hard coronary events in the population-based Heinz Nixdorf Recall study.
    Frey UH; Moebus S; Möhlenkamp S; Kälsch H; Bauer M; Lehmann N; Nöthen M; Mühleisen TW; Stang A; Erbel R; Jöckel KH; Peters J; Siffert W
    Atherosclerosis; 2014 Dec; 237(2):437-42. PubMed ID: 25463071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positive Association of the
    Kunnas T; Nikkari ST
    Genet Test Mol Biomarkers; 2020 Oct; 24(10):681-684. PubMed ID: 32721243
    [No Abstract]   [Full Text] [Related]  

  • 54. Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population.
    Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Hartley O; Montecucco F; Mach F; Kutalik Z; Waeber G; Vollenweider P; Vuilleumier N
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2342-2349. PubMed ID: 29074586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic Disorders.
    Allu PKR; Kiranmayi M; Mukherjee SD; Chirasani VR; Garg R; Vishnuprabu D; Ravi S; Subramanian L; Sahu BS; Iyer DR; Maghajothi S; Sharma S; Ravi MS; Khullar M; Munirajan AK; Gayen JR; Senapati S; Mullasari AS; Mohan V; Radha V; Naga Prasad SV; Mahapatra NR
    Diabetes; 2022 Mar; 71(3):538-553. PubMed ID: 34862200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polygenic risk scores for cardiovascular diseases and type 2 diabetes.
    Wong CK; Makalic E; Dite GS; Whiting L; Murphy NM; Hopper JL; Allman R
    PLoS One; 2022; 17(12):e0278764. PubMed ID: 36459520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity.
    Beekman M; Nederstigt C; Suchiman HE; Kremer D; van der Breggen R; Lakenberg N; Alemayehu WG; de Craen AJ; Westendorp RG; Boomsma DI; de Geus EJ; Houwing-Duistermaat JJ; Heijmans BT; Slagboom PE
    Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18046-9. PubMed ID: 20921414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score--the CoLaus Study.
    Lin X; Song K; Lim N; Yuan X; Johnson T; Abderrahmani A; Vollenweider P; Stirnadel H; Sundseth SS; Lai E; Burns DK; Middleton LT; Roses AD; Matthews PM; Waeber G; Cardon L; Waterworth DM; Mooser V
    Diabetologia; 2009 Apr; 52(4):600-8. PubMed ID: 19139842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic cardiovascular risk prediction: will we get there?
    Thanassoulis G; Vasan RS
    Circulation; 2010 Nov; 122(22):2323-34. PubMed ID: 21147729
    [No Abstract]   [Full Text] [Related]  

  • 60. Presymptomatic risk assessment for chronic non-communicable diseases.
    Padhukasahasram B; Halperin E; Wessel J; Thomas DJ; Silver E; Trumbower H; Cargill M; Stephan DA
    PLoS One; 2010 Dec; 5(12):e14338. PubMed ID: 21217814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.